Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. License and Development Agreement By and between Arrow International Limited 57 St. Christopher Street Valletta, VLT 08, Malta...License and Development Agreement • August 8th, 2008 • Sepracor Inc /De/ • Pharmaceutical preparations • New York
This License and Development Agreement (this "Agreement"), dated as of April 30, 2008 is being entered into by and between Arrow International Limited, a Malta corporation having its principal office at 57 St. Christopher Street, Valletta, VLT 08, Malta, and its Affiliates (collectively referred to as "Arrow"), and Sepracor Inc., a corporation organized and existing under the laws of the State of Delaware and having its principal office at 84 Waterford Drive, Marlborough, MA 01752, USA ("Sepracor"). Each or both of Arrow and Sepracor are hereinafter referred to as "Party" or "Parties", as intended in the given context.
EMPLOYMENT AGREEMENTEmployment Agreement • August 8th, 2008 • Sepracor Inc /De/ • Pharmaceutical preparations • Massachusetts
THIS EMPLOYMENT AGREEMENT (the "Agreement"), made this 14th day of May 2008 (the "Effective Date"), is entered into by Sepracor Inc., a Delaware corporation with its principal place of business at 84 Waterford Drive, Marlborough, Massachusetts 01752-7231(the "Company"), and Robert F. Scumaci, residing at 174 Clinton Street, Hopkinton, MA 01748 (the "Executive").
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. SETTLEMENT AND LICENSE AGREEMENTSettlement and License Agreement • August 8th, 2008 • Sepracor Inc /De/ • Pharmaceutical preparations • Massachusetts
This SETTLEMENT AND LICENSE AGREEMENT (this "Agreement") is made and effective as of April 30, 2008 (the "Effective Date"), by and between Sepracor Inc., a Delaware corporation having its principal place of business at 84 Waterford Drive, Marlborough, MA 10752 ("Sepracor"), and Breath Limited, a United Kingdom corporation having its registered address at 930 High Road, London, N12 9RT, United Kingdom ("Breath Limited") (each a "Party" and collectively, the "Parties").
SEVERANCE AND CONSULTING AGREEMENTSeverance and Consulting Agreement • August 8th, 2008 • Sepracor Inc /De/ • Pharmaceutical preparations • Massachusetts
This Severance and Consulting Agreement (the "Agreement") is made and entered into between DAVID SOUTHWELL ("SOUTHWELL" or "you" or "your") and SEPRACOR INC. ("SEPRACOR"), collectively referred to herein as the "Parties" this 14th day of May 2008.
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. SUPPLY AGREEMENTSupply Agreement • August 8th, 2008 • Sepracor Inc /De/ • Pharmaceutical preparations • Massachusetts
This SUPPLY AGREEMENT (this "Supply Agreement") is made and effective as of April 30, 2008 (the "Effective Date"), by and between Sepracor Inc., a Delaware corporation having its principal place of business at 84 Waterford Drive, Marlborough, MA 10752 ("Sepracor"), and Breath Limited, a United Kingdom corporation having its registered address at 930 High Road, London, N12 9RT, United Kingdom ("Breath Limited") (each a "Party" and collectively, the "Parties").
SHARE PURCHASE AGREEMENTShare Purchase Agreement • August 8th, 2008 • Sepracor Inc /De/ • Pharmaceutical preparations • Ontario
COBALT PHARMACEUTICALS INC. ("Cobalt"), a corporation incorporated under the laws of the Province of Ontario, and MELVILLE HOLDINGS LIMITED ("Melville"), a corporation incorporated under the laws of Malta,
